Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
UZEDY: Information from Industry
View All
Letter to the Editor
Page 120
Recently published articles about
Letter to the Editor
JCP
Letter to the Editor
"Reply to Lithium Dosing Schedule and Renal Isufficiency"
March 15, 2005
Elie Lepkifker
JCP
Letter to the Editor
"Reply to Single Versus Multiple Daily Dosing of Lithium: Renal Effects
March 15, 2005
Elie Lepkifker
JCP
Letter to the Editor
Serious Rash With Lamotrigine After Carbamazepine Discontinuation: A Case Report
March 15, 2005
Rif S. El-Mallakh
,
Anton A. Subuh Surja
,
Kathryn E. Brotzge
JCP
Letter to the Editor
Single Versus Multiple Daily Dosing of Lithium: Renal Effects
March 15, 2005
Chekkera Shammi
JCP
Letter to the Editor
A Case of Complex Movement Disorder Induced by Fluoxetine With Management of Dystonia by Botulinum Toxin Type A
February 15, 2005
J. Chen
,
David M. Swope
JCP
Letter to the Editor
Diabetes Mellitus During Olanzapine and Quetiapine Treatment in Japan
February 15, 2005
Dan Cohen
JCP
Letter to the Editor
Obesity and Mood Disorders: The Complex Problem of Insight
February 15, 2005
Valdo Ricca
,
Claudia Ravaldi
,
Edoardo Barboni
, et al
JCP
Letter to the Editor
Olanzapine-Induced Hyperprolactinemia and Galactorrhea Reversed With Addition of Bromocriptine: A Case Report
February 15, 2005
David E. Miller
,
C. Simon Sebastian
JCP
Letter to the Editor
New Onset of Diabetes Mellitus With Ziprasidone: A Case Report
February 15, 2005
Pablo Sánchez-Barranco
PCC
Letter to the Editor
Resolution of Ziprasidone-Related Tardive Dyskinesia With a Switch to Aripiprazole
February 15, 2005
Ashish Sharma
,
Sriram Ramaswamy
,
Vijay K. Dewan
JCP
Letter to the Editor
Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics.
January 15, 2005
James L. Karagianis
,
Eduardo Dunayevich
JCP
Letter to the Editor
Dr. Ananth Replies to Drs. Carroll and Lee "Catatonia Is a Risk Factor for Neuroleptic Malignant Syndrome."
January 15, 2005
Jambur Ananth
«
1
…
118
119
120
121
122
…
176
»
